Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Volatility-adjusted returns show how total market funds stack up against SP 500 over time, highlighting stability versus peak swings for retirement savings.
28,240 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Fixed notes are more than a loan term. They can be a proactive hedge against vacancy gaps. Learn how investors using ...
PepsiCo stock faces a fresh price prediction this popular blue-chip dividend stock, with an upside case built on inte...
A wave of altcoins posted double-digit gains while Bitcoin steadied. Learn which coins led the rally, why it happened...
Netflix reports strong cash generation as Disney funds parks and legacy assets with heavy capex, spotlighting two dis...
Ford posted solid Q1 results with rising revenue and a booming software business, while GM delivered a robust earning...
A top Nomura strategist says equities are priced for chaos, but the odds of a sweeping market crash remain low as dat...
As technology stocks dominate the market, smart money fleeing tech may seek ballast in Johnson & Johnson. This articl...
As Sempra wraps up the 2025 fiscal year, investors want clarity on the Q4 2025 earnings trajectory. This article brea...
Gold has emerged as a standout performer in 2026, with certain bullion-backed ETFs delivering resilience and steady g...
Two popular growth-focused ETFs, VUG and IWO, take different paths to US growth. One leans into large-cap power with ...
Friday brought a surprising turn for Bitcoin as it slipped alongside rising yields and shifting market sentiment. Thi...